Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ -0.17% slumped 0.23% to $163.40 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +2.15% rising 0.30% to 4,549.78 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +1.49% falling 0.02% to 35,603.08. This was the stock's second consecutive day of losses. Johnson & Johnson closed $16.52 short of its 52-week high ($179.92), which the company reached on August 20th.
The stock underperformed when compared to some of its competitors Thursday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/composite RHHVF +0.98% rose 3.82% to $393.00, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK -2.16% rose 0.12% to $81.17, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE -0.46% rose 0.14% to $42.86. Trading volume (4.5 M) remained 1.6 million below its 50-day average volume of 6.1 M.